Autonomix Medical (AMIX) Convertible Debt (2024)

Autonomix Medical (AMIX) reported Convertible Debt of $1.1 million for Q3 2024, up 4.12% quarter-over-quarter from $1.0 million in Q2 2024.

Autonomix Medical (AMIX) Convertible Debt (2024) Analysis & Trends

Autonomix Medical (AMIX) has 1 years of Convertible Debt data on file, last reported at $1.1 million in Q3 2024.

Convertible Debt for Q3 2024 came in at $1.1 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $1.1 million (changed N/A YoY), and the FY2024 annual result was $1.0 million, changed N/A from the prior year.
Convertible Debt climbed to $1.1 million in Q3 2024 per AMIX's latest filing, from $1.0 million in the prior quarter.
Over five years, Convertible Debt peaked at $1.1 million in Q3 2024 and troughed at $1.0 million in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn
10	Autonomix Medical	3.33 Mn	3.33 Mn	-

Download Data